Infertility Drugs Market by Product and Geography - Forecast and Analysis 2020-2024

The infertility drugs market share is expected to increase by USD 1.03 billion from 2019 to 2024, and the market's growth momentum will accelerate at a CAGR of 4.82%.

This infertility drugs market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers infertility drugs market segmentations by product (hormone-based therapy and others) and geography (North America, Europe, APAC, and South America). The infertility drugs market report also offers information on several market vendors, including AbbVie Inc., Allergan Plc, Bayer AG, Ferring Pharmaceuticals AS, GlaxoSmithKline Plc, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., and Sanofi among others.

What will the Infertility Drugs Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Infertility Drugs Market Size for the Forecast Period and Other Important Statistics

 

Infertility Drugs Market: Key Drivers, Trends, and Challenges

Based on our research output, there has been a neutral impact on the market growth during and post COVID-19 era. The growing lifestyle diseases is notably driving the infertility drugs market growth, although factors such as rising inclination toward other modes of treatment for infertility may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the infertility drugs industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Infertility Drugs Market Driver

The rising trend of late parenthood is a key driving factor impacting the global infertility drugs market growth. Increased age of parenthood is one of the major factors leading to the infertility problem in the present generation. In fact, it has severely affected European countries and some Asian countries such as Japan. This growing trend of late motherhood is against the natural range of fertile years for women, which significantly brightens the prospects for the global infertility drugs market. Factors such as the growing use of various contraceptive technologies, increasing focus on higher education and career, and urbanization have led to the rising median age of first pregnancy, leading to falling fertility rates. Globally, more women are working than ever before, which has also increased the average age of conceiving a child. Such factors are creating more complications and often lead to infertility.

Key Infertility Drugs Market Trend

Raising awareness regarding infertility in couples is a key trend impacting the global infertility drugs market growth. There is growing awareness about sexual health, such as fertility issues across the globe. This is expected to act as a positive trend in the infertility treatment industry. Different government and non-government organizations across the globe are supporting the couples to come forward and discuss their problems and seek professional help to tackle their issues. For instance, the International Fertility Alliance (IFA) is on a mission to spread awareness about fertility issues and provide support to people with fertility-related issues. Additionally, the National Fertility Association founded the National Infertility Awareness Week, which focuses on providing the right information and answering queries about infertility.

Key Infertility Drugs Market Challenge

The rising inclination toward other modes of treatment for infertility is a key challenge negatively impacting the global infertility drugs market growth. Rising preference for other modes of treatment such as assisted reproductive technology (ART) is posing tough competition for the infertility drugs market. In developed countries, couples having problems conceiving children are inclining toward ART. IVF is the most adopted form of ART treatment. Some of the other forms of treatment for infertility are listed below. Artificial insemination/Intrauterine insemination (IUI) involves direct injection of sperm into the uterus via a thin, flexible catheter. Couples that face low sperm count in the male partner opt for such treatments.

This infertility drugs market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2020-2024.

Parent Market Analysis

Technavio categorizes the global Infertility drugs market is a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the infertility drugs market during the forecast period.

Who are the Major Infertility Drugs Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

• AbbVie Inc.
• Allergan Plc
• Bayer AG
• Ferring Pharmaceuticals AS
• GlaxoSmithKline Plc
• Merck & Co. Inc.
• Merck KGaA
• Novartis AG
• Pfizer Inc.
• Sanofi

 

This statistical study of the infertility drugs market encompasses successful business strategies deployed by the key vendors. The infertility drugs market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market.

Product Insights and News

• Bayer AG - The company offers infertility drug by brand name Fostine.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The infertility drugs market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Infertility Drugs Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the infertility drugs market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

The report has further elucidated on other innovative approaches being followed by manufacturers to ensure a sustainable market presence.

Which are the Key Regions for Infertility Drugs Market?

For more insights on the market share of various regions Request for a FREE sample now!

36% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for the infertility drugs market in North America. Market growth in this region will be faster than the growth of the South American market.

An increase in infertility risk factors, among which sexually transmitted diseases (STDs), endometriosis, polycystic ovary syndrome (PCOS), poor diet, age, and diabetes are the major risk factors that will facilitate the infertility drugs market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

What are the Revenue-generating Product Segments in the Infertility Drugs Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The infertility drugs market share growth by the hormone-based therapy segment will be significant during the forecast period. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the infertility drugs market size and actionable market insights on post COVID-19 impact on each segment.

 

Infertility Drugs Market Scope
Report Coverage	Details
Page number	120
Base year	2019
Forecast period	2020-2024
Growth momentum & CAGR	Accelerate at a CAGR of 4.82%
Market growth 2020-2024	$ 1.03 billion
Market structure	Fragmented
YoY growth (%)	4.67
Regional analysis	North America, Europe, APAC, and South America
Performing market contribution	North America at 36%
Key consumer countries	US, UK, Canada, China, and Germany
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	AbbVie Inc., Allergan Plc, Bayer AG, Ferring Pharmaceuticals AS, GlaxoSmithKline Plc, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., and Sanofi
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Infertility Drugs Market Report?

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will drive infertility drugs market growth during the next five years
• Precise estimation of the infertility drugs market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the infertility drugs industry across North America, Europe, APAC, and South America
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of infertility drugs market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch